GlassScriptPhysician profile
Randall Wayne Jennings
NPI 1467449827
$4,735.65
in general payments reported to CMS, 2019-2025
15 companies · $642 in 2025
The $642 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,347 · 2020: $1,255 · 2021: $275 · 2022: $579 · 2023: $638 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816 · Entertainment: $238 · Travel and Lodging: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.50 |
| Entertainment | $238.21 |
| Travel and Lodging | $225.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $2,188.55 | 2019-2023 | |
| Medacta USA, INC. | $485.94 | 2025 | Amistem |
| Arthrex, INC. | $398.55 | 2020-2025 | |
| Stryker Corporation | $340.61 | 2019 | |
| Zimmer Biomet Holdings, INC. | $264.07 | 2021-2022 | |
| Curvebeam LLC | $238.21 | 2023 | |
| Smith+Nephew, INC. | $222.94 | 2022 | |
| Heron Therapeutics, INC. | $199.27 | 2019-2025 | Zynrelef |
| Miach Orthopaedics, INC. | $142.00 | 2022 | |
| Depuy Synthes Sales INC. | $84.84 | 2021 | |
| Biom'Up Sa | $57.75 | 2019 | |
| Vericel Corporation | $48.42 | 2019-2020 | |
| Innovation Technologies INC | $31.44 | 2021 | |
| Alon Medical Technology | $19.36 | 2023 | |
| Pfizer INC. | $13.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Jennings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.